Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3520 ARTÍCULOS , VIENDO DEL 1681 AL 1695

Actively transported levodopa prodrug XP21279: a study in patients with Parkinson disease who experience motor fluctuations

Lewitt PA, Ellenbogen A, Chen D, Lal R, McGuire K, Zomorodi K, Luo W, Huff FJ.

Clin Neuropharmacol. 2012 May-Jun;35(3):103-10. doi: 10.1097/WNF.0b013e31824e4d7d.

Pneumonia and encephalopathy in a patient with progressing Parkinson's disease and dementia

Livesay S, Ruppert SD.

Crit Care Nurs Q. 2012 Apr-Jun;35(2):160-72. doi: 10.1097/CNQ.0b013e31824565e0.

7-[ (11)C]Methoxy-1-methyl-9H-[3,4-b]indole

Leung K.

2006 Jun 23 [updated 2012 Mar 14]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013.

Predictors of treatment response to cognitive-behavioral therapy for depression in Parkinson's disease

Dobkin RD, Rubino JT, Allen LA, Friedman J, Gara MA, Mark MH, Menza M.

J Consult Clin Psychol. 2012 Aug;80(4):694-9. doi: 10.1037/a0027695. Epub 2012 Mar 12.

Investigation of the antidyskinetic site of action of metabotropic and ionotropic glutamate receptor antagonists. Intracerebral infusions in 6-hydroxydopamine-lesioned rats with levodopa-induced dyskinesia

Maranis S, Stamatis D, Tsironis C, Konitsiotis S.

Eur J Pharmacol. 2012 May 15;683(1-3):71-7. doi: 10.1016/j.ejphar.2012.02.036. Epub 2012 Mar 4.

Proteomic profiling of the substantia nigra demonstrates CNDP2 overexpression in Parkinson's disease

Licker V, Côte M, Lobrinus JA, Rodrigo N, Kövari E, Hochstrasser DF, Turck N, Sanchez JC, Burkhard PR.

J Proteomics. 2012 Aug 3;75(15):4656-67. doi: 10.1016/j.jprot.2012.02.032. Epub 2012 Mar 6.

Advanced glycation end products and neurodegenerative diseases: mechanisms and perspective

Li J, Liu D, Sun L, Lu Y, Zhang Z.

J Neurol Sci. 2012 Jun 15;317(1-2):1-5. doi: 10.1016/j.jns.2012.02.018. Epub 2012 Mar 11.

Cardiac electrophysiology and the athlete: a primer for the sports clinician

Stoebner R, Bellin DA, Haigney MC.

Curr Sports Med Rep. 2012 Mar-Apr;11(2):70-7. doi: 10.1249/JSR.0b013e31824cf347.

Converted neural cells: induced to a cure?

Zhang W, Duan S, Li Y, Xu X, Qu J, Zhang W, Liu GH.

Protein Cell. 2012 Feb;3(2):91-7. doi: 10.1007/s13238-012-2029-2. Epub 2012 Mar 11.

Mitochondrial importance in Alzheimer's, Huntington's and Parkinson's diseases

Correia SC, Santos RX, Perry G, Zhu X, Moreira PI, Smith MA.

Adv Exp Med Biol. 2012;724:205-21. doi: 10.1007/978-1-4614-0653-2_16.

A novel synonymous SNP in PITX3 is associated with Parkinson's disease in Chinese population

Gui Y, Zhao Y, Liu H, Fu J, Xu Z, Hu X.

Swiss Med Wkly. 2012 Mar 9;142:w13521. doi: 10.4414/smw.2012.13521. eCollection 2012.

Autonomic failure following deep brain stimulation for Parkinson's disease

Williams SE, Ernst T, Birns J.

Br J Hosp Med (Lond). 2012 Mar;73(3):170-1. doi: 10.12968/hmed.2012.73.3.170.

Deep brain stimulation of the subthalamic nucleus improves sense of well-being in Parkinson's disease

McDonald LM, Page D, Wilkinson L, Jahanshahi M.

Mov Disord. 2012 Mar;27(3):372-8. doi: 10.1002/mds.24035. Epub 2012 Jan 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias